Published in Nature on January 22, 2014
Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 16.13
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
A polygenic burden of rare disruptive mutations in schizophrenia. Nature (2014) 5.99
The contribution of de novo coding mutations to autism spectrum disorder. Nature (2014) 5.94
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Schizophrenia risk from complex variation of complement component 4. Nature (2016) 3.84
Large-scale discovery of novel genetic causes of developmental disorders. Nature (2014) 3.33
Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet (2014) 3.21
Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. Nat Neurosci (2015) 2.89
A trans-synaptic nanocolumn aligns neurotransmitter release to receptors. Nature (2016) 2.45
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci (2015) 2.43
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet (2014) 2.20
Synaptic dysregulation in a human iPS cell model of mental disorders. Nature (2014) 2.12
IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry (2014) 2.05
Schizophrenia. Lancet (2016) 1.83
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci (2016) 1.78
A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet (2016) 1.75
Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci (2014) 1.64
Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1. Cell Stem Cell (2015) 1.63
Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun (2014) 1.59
Structural basis of arc binding to synaptic proteins: implications for cognitive disease. Neuron (2015) 1.58
Altered Expression of CDC42 Signaling Pathway Components in Cortical Layer 3 Pyramidal Cells in Schizophrenia. Biol Psychiatry (2015) 1.56
Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes. PLoS One (2014) 1.55
Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Biol Psychiatry (2015) 1.52
L1-associated genomic regions are deleted in somatic cells of the healthy human brain. Nat Neurosci (2016) 1.51
Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies. Transl Psychiatry (2015) 1.49
Evolution of complexity in the zebrafish synapse proteome. Nat Commun (2017) 1.47
Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins. Proteomics (2015) 1.46
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One (2016) 1.45
Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery. Genome Biol (2016) 1.43
Annual Research Review: Discovery science strategies in studies of the pathophysiology of child and adolescent psychiatric disorders - promises and limitations. J Child Psychol Psychiatry (2016) 1.42
Genetic studies in intellectual disability and related disorders. Nat Rev Genet (2015) 1.40
The PsychENCODE project. Nat Neurosci (2015) 1.39
The discovery of integrated gene networks for autism and related disorders. Genome Res (2014) 1.35
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry (2015) 1.29
Evaluating historical candidate genes for schizophrenia. Mol Psychiatry (2015) 1.26
A role for noncoding variation in schizophrenia. Cell Rep (2014) 1.26
Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci (2014) 1.21
Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice. Genome Med (2014) 1.17
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol (2015) 1.16
Psychiatric disorders: diagnosis to therapy. Cell (2014) 1.16
Autism spectrum disorder severity reflects the average contribution of de novo and familial influences. Proc Natl Acad Sci U S A (2014) 1.16
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat Rev Genet (2015) 1.14
Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry (2014) 1.11
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. Curr Opin Pharmacol (2014) 1.11
De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. Cell Rep (2014) 1.10
Patterns of genic intolerance of rare copy number variation in 59,898 human exomes. Nat Genet (2016) 1.10
Genetics and genomics of psychiatric disease. Science (2015) 1.08
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? Schizophr Res (2014) 1.06
Detection and phasing of single base de novo mutations in biopsies from human in vitro fertilized embryos by advanced whole-genome sequencing. Genome Res (2015) 1.06
Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences. Hum Mol Genet (2014) 1.03
Transcriptional targets of the schizophrenia risk gene MIR137. Transl Psychiatry (2014) 1.02
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet (2016) 1.02
The molecular bases of the suicidal brain. Nat Rev Neurosci (2014) 1.02
Identification and functional characterization of rare SHANK2 variants in schizophrenia. Mol Psychiatry (2015) 1.01
Classification of behaviorally defined disorders: biology versus the DSM. J Autism Dev Disord (2014) 1.01
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia. Neuron (2015) 1.00
Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci (2016) 1.00
Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Mol Psychiatry (2015) 0.99
A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. Am J Hum Genet (2014) 0.99
Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases. Neuron (2015) 0.98
Modeling psychiatric disorders for developing effective treatments. Nat Med (2015) 0.98
Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry (2014) 0.98
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat Neurosci (2016) 0.97
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators. Cell Rep (2015) 0.96
LKB1 and AMPK differentially regulate pancreatic β-cell identity. FASEB J (2014) 0.96
Genome-scale neurogenetics: methodology and meaning. Nat Neurosci (2014) 0.96
The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders. Neuropsychopharmacology (2015) 0.96
Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia. Biol Psychiatry (2014) 0.95
Co-barcoded sequence reads from long DNA fragments: a cost-effective solution for "perfect genome" sequencing. Front Genet (2015) 0.94
Actin Out: Regulation of the Synaptic Cytoskeleton. J Biol Chem (2015) 0.94
Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron (2015) 0.94
The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry (2014) 0.93
De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Schizophr Res (2015) 0.93
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann N Y Acad Sci (2014) 0.92
A case of autism spectrum disorder arising from a de novo missense mutation in POGZ. J Hum Genet (2015) 0.92
Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates. Neurosci Bull (2015) 0.91
Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures. Am J Hum Genet (2016) 0.91
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet (2017) 0.91
An Expanded View of Complex Traits: From Polygenic to Omnigenic. Cell (2017) 0.91
In search of rare variants: preliminary results from whole genome sequencing of 1,325 individuals with psychophysiological endophenotypes. Psychophysiology (2014) 0.91
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity. Curr Neuropharmacol (2017) 0.90
Rbm8a haploinsufficiency disrupts embryonic cortical development resulting in microcephaly. J Neurosci (2015) 0.90
A Bayesian framework for de novo mutation calling in parents-offspring trios. Bioinformatics (2014) 0.90
POGZ truncating alleles cause syndromic intellectual disability. Genome Med (2016) 0.90
An expanded sequence context model broadly explains variability in polymorphism levels across the human genome. Nat Genet (2016) 0.90
The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity. PLoS Genet (2015) 0.90
CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome. Front Cell Neurosci (2014) 0.89
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol (2015) 0.89
Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med (2015) 0.89
EvoTol: a protein-sequence based evolutionary intolerance framework for disease-gene prioritization. Nucleic Acids Res (2014) 0.89
Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol (2014) 0.88
Schizophrenia genetics: emerging themes for a complex disorder. Mol Psychiatry (2014) 0.88
New insights into the generation and role of de novo mutations in health and disease. Genome Biol (2016) 0.88
Calibrating the Human Mutation Rate via Ancestral Recombination Density in Diploid Genomes. PLoS Genet (2015) 0.88
NMDA receptors are selectively partitioned into complexes and supercomplexes during synapse maturation. Nat Commun (2016) 0.88
A review of study designs and statistical methods for genomic epidemiology studies using next generation sequencing. Front Genet (2015) 0.88
Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Mol Psychiatry (2014) 0.87
Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci (2014) 0.87
Arc regulates experience-dependent persistent firing patterns in frontal cortex. J Neurosci (2014) 0.87
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Rate of de novo mutations and the importance of father's age to disease risk. Nature (2012) 11.92
Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med (2012) 10.80
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell (2011) 8.46
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 8.42
Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry (2007) 7.00
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
A polygenic burden of rare disruptive mutations in schizophrenia. Nature (2014) 5.99
Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet (2010) 5.78
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron (2011) 4.66
The Kraepelinian dichotomy - going, going... but still not gone. Br J Psychiatry (2010) 4.47
Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med (2012) 4.36
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res (1984) 4.28
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet (2012) 3.49
Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology (2009) 3.27
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron (2011) 3.08
NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci (1993) 2.76
KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature (2012) 2.47
The Arc of synaptic memory. Exp Brain Res (2009) 2.30
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci (2011) 2.18
Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nat Cell Biol (2010) 2.18
De novo rates and selection of schizophrenia-associated copy number variants. Biol Psychiatry (2011) 1.87
Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry (2011) 1.87
Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A (2010) 1.85
The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci (2013) 1.81
The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron (2012) 1.71
Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell (2013) 1.70
Arc in synaptic plasticity: from gene to behavior. Trends Neurosci (2011) 1.69
A family-based study of common polygenic variation and risk of schizophrenia. Mol Psychiatry (2011) 1.44
A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiatr Scand (2010) 1.10
TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. J Neurosci (2012) 1.10
Arc/Arg3.1 is a postsynaptic mediator of activity-dependent synapse elimination in the developing cerebellum. Neuron (2013) 1.10
Organization of brain complexity--synapse proteome form and function. Brief Funct Genomic Proteomic (2006) 1.00
SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations. Nucleic Acids Res (2012) 0.98
Genetics: Fish heads and human disease. Nature (2012) 0.88
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
A polygenic burden of rare disruptive mutations in schizophrenia. Nature (2014) 5.99
Schizophrenia risk from complex variation of complement component 4. Nature (2016) 3.84